| Accession |
PRJCA016022 |
| Title |
A Phase II Trial of CNCT19 Cell Injection for the Treatment of CD19-Positive Relapse/Refractory Acute Lymphoblastic Leukemia |
| Relevance |
Medical |
| Data types |
Phenotype or Genotype
|
| Organisms |
Homo sapiens
|
| Description |
A Phase II Trial of CNCT19 Cell Injection for the Treatment of CD19-Positive Relapse/Refractory Acute Lymphoblastic Leukemia |
| Sample scope |
Multiisolate |
| Release date |
2023-03-30 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
Yinling
Wu (wuyinling@juventas.cn)
|
| Organization |
Heyuan Biotechnology (Tianjin) limited company |
| Submission date |
2023-03-30 |
